Latest Canada News

Immuron delivered record FY26 sales, a narrower loss and a much stronger cash balance, while shifting clinical development towards commercial partners. The annual report also flags a material weakness in inventory controls and confirms that IMM-529 remains dependent on a future licensing deal.

Peako has completed its 100% acquisition of six Saudi Arabian gold projects covering 862 square kilometres, clearing the way for maiden drilling from October. Recent fieldwork has identified extensive high-grade vein systems, but the reported grades remain exploration indicators rather than a mineral resource.

Iron Bear Resources says a new federal-provincial assessment framework, major Labrador clean-energy investment and strategic-project coordination could improve the development pathway for its Canadian iron ore project. The initiatives are supportive, but they do not yet represent project approvals, secured power or construction funding.

4DMedical delivered sharp growth in scans, sites and operating revenue as CT:VQ moved into commercial deployment across several global markets. But the company remains loss-making and its auditor issued a qualified opinion over the carrying value of goodwill and other intangible assets.

Atomic Eagle has formally executed the Mining Convention for its Madaouela uranium project in Niger, securing the legal, fiscal and operational framework for the asset. The agreement also triggers steps to end historical arbitration proceedings, while a US$5 million payment and a targeted JORC resource update now sit ahead of the company.

Powerhaus Uranium entered the ASX with a $2.14 million annual loss, $1.51 million operating cash outflow and net liabilities at 30 June 2026. A subsequent $9 million IPO and the Hidden Bay acquisition have given the early-stage explorer a larger exploration runway, but drilling remains subject to approvals and future funding will still matter.

Reward Minerals has begun the first-ever drilling at its Mountain Pond project in Newfoundland, testing whether a surface quartz vein and shear zone continues underground. New soil results have also outlined copper targets at Ante Up and Wildcard, but the project remains firmly in the discovery phase.

Rua Bioscience delivered a sharp rise in customer revenue and secured a UK agreement expected to generate NZ$10 million over two years. But PwC disclaimed an audit opinion, warning the company may not have enough cash without another capital raise.

Michael Hill International has returned to profit growth and restored its dividend after a year of sharper execution, brand simplification and stronger cash generation. Record revenue and a 57% rise in comparable EBIT mark a meaningful recovery, although the reset remains unfinished.

Biome Australia Limited (ASX:BIO) delivered its second consecutive profitable year in FY26, with revenue rising 30% to $23.9 million and operating cash flow turning positive. But the headline $3.6 million profit includes a $2.4 million deferred tax benefit, leaving FY27 execution as the real test of the company’s growth plan.

Orthocell has recorded the first commercial sales of its Remplir nerve repair product in Thailand, opening a new market estimated at US$84 million. The launch gives the company another distributor-led growth channel, although near-term sales are expected to remain modest.

Telix will acquire ITM in a proposed US$1.65 billion deal that combines a commercial radioisotope supplier with Telix’s precision medicine and therapeutic pipeline. The transaction could give Telix greater supply-chain control and entry into a validated cancer treatment market, but it also brings dilution, integration risk and an unresolved FDA pathway for ITM-11.